CACNA1B encodes the alpha-1B subunit of N-type voltage-gated calcium channels (CaV2.2), which are critical for calcium-dependent neurotransmitter release and synaptic transmission 1. The channel mediates calcium entry into excitable cells and plays essential roles in neuronal excitability, particularly in pain pathways where it serves as a target for analgesics like ziconotide and gabapentin 1. The channel's activity is modulated by protein kinase A phosphorylation through the calcium-channel inhibitor Rad, which when phosphorylated, relieves constitutive inhibition and increases channel open probability 2. CACNA1B shows significant disease relevance, with rare variants contributing to bipolar disorder risk through effects on neuronal excitability pathways 34. Additionally, frameshift mutations in CACNA1B have been identified in adult-onset isolated focal dystonia, suggesting a role in movement disorders 5. Clinically, CACNA1B represents a promising therapeutic target for pain management, with novel selective blockers showing efficacy across multiple pain models while preserving protective pain responses and avoiding motor or cardiovascular side effects 1. The gene also shows overexpression in various cancers, though its oncogenic mechanisms require further investigation 67.